FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Published at www.nejm.org November 17, 2009 (10.1056/NEJMe0910394)

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Disclosures Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Traditionally, the only definitive therapy for patients who have advanced, medically refractory heart failure was replacement of the heart with another human heart. However, transplantation is an inadequate option in light of the large number of potential candidates, the lack of donors, and the coexisting conditions that make most potential candidates ineligible for transplantation. In this context, ventricular assist devices, or heart pumps, become an attractive option for patients who have advanced heart failure.

Rather than replacing the human heart completely, ventricular assist devices serve in a true "assistance" capacity by supplementing the cardiac output of the native but weakened . . . [Full Text of this Article]

Source Information

From the Harrington–McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, and the Division of Cardiovascular Medicine, Case Western Reserve University — both in Cleveland.

This article (10.1056/NEJMe0910394) was published on November 17, 2009, at NEJM.org.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved.